A notable advancement in diabetes care is emerging with the introduction of tirzepatide at a dosage of 45mg. This innovative version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://7bookmarks.com/story21177855/significant-development-tirzepatide-dose-for-glucose-regulation